Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 2/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL299771 | 1.00 | AKR1C3 (0.57) | AKR1C3PTGS2AKR1C2AKR1C1 | |
| SCHEMBL9284800 | 0.84 | MTNR1A (0.45) | AKR1C1 | |
| SCHEMBL7756538 | 0.81 | MTNR1A (0.49) | AKR1C1 | |
| SCHEMBL7603630 | 0.81 | MTNR1A (0.49) | AKR1C1 | |
| SCHEMBL7603627 | 0.81 | MTNR1A (0.49) | AKR1C1 | |
| SCHEMBL14045283 | 0.78 | AKR1C3 (0.55) | AKR1C3PTGS2AKR1C2AKR1C1 | |
| SCHEMBL10339712 | 0.71 | MEN1 (0.42) | AKR1C3AKR1C1 | |
| SCHEMBL7604413 | 0.70 | ESR1 (0.61) | PTGS2 | |
| SCHEMBL7604418 | 0.70 | ESR1 (0.61) | PTGS2 | |
| SCHEMBL7758219 | 0.70 | ESR1 (0.61) | PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240139027-A1 | DIAGNOSTIC METHODS AND APPARATUS | FORSIGHT VISION4, INC. | 2024-05-02 | — | — | US | disclosed |
| US-11813196-B2 | Diagnostic methods and apparatus | FORSIGHT VISION4, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230338282-A1 | POSTERIOR SEGMENT DRUG DELIVERY | FORSIGHT VISION4, INC. | 2023-10-26 | — | — | US | disclosed |
| US-11786396-B2 | Injector apparatus and method for drug delivery | FORSIGHT VISION4, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| EP-3799844-B1 | IMPLANTABLE OCULAR DRUG DELIVERY DEVICES | FORSIGHT VISION4 INC (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-4249059-A2 | AN APPARATUS FOR COLLECTING A SAMPLE OF FLUID FROM A RESERVOIR CHAMBER OF A THERAPEUTIC DEVICE FOR THE EYE | ForSight Vision4, Inc. (US) | 2023-09-27 | — | — | EP | disclosed |
| US-20230225903-A1 | IMPLANTABLE OCULAR DRUG DELIVERY DEVICES | FORSIGHT VISION4, INC. | 2023-07-20 | — | — | US | disclosed |
| EP-2726016-B1 | AN APPARATUS FOR COLLECTING A SAMPLE OF FLUID FROM A RESERVOIR CHAMBER OF A THERAPEUTIC DEVICE FOR THE EYE | FORSIGHT VISION4 INC (US) | 2023-07-19 | — | — | EP | disclosed |
| US-11679027-B2 | Combined drug delivery methods and apparatus | FORSIGHT VISION4, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| US-11642310-B2 | Posterior segment drug delivery | FORSIGHT VISION4, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20060264453-A1 | Rapamycin formulations and methods of their use | MACUSIGHT, INC. (US) | 2006-11-23 | — | — | US | disclosed |
| US-20060257450-A1 | Drug delivery systems for treatment of diseases or conditions | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2006-11-16 | — | — | US | disclosed |
| US-20060258698-A1 | Liquid formulations for treatment of diseases or conditions | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2006-11-16 | — | — | US | disclosed |
| WO-2006102378-A2 | DRUG DELIVERY SYSTEMS FOR TREATMENT OF DISEASES OR CONDITIONS | MACUSIGHT, INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006086750-A1 | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS | MACUSIGHT, INC. (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006086744-A1 | FORMULATIONS FOR OCULAR TREATMENT | MACUSIGHT, INC. (US) | 2006-08-17 | — | — | WO | disclosed |
| US-20060182771-A1 | Formulations for ocular treatment | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2006-08-17 | — | — | US | disclosed |
| EP-1682132-A1 | TRANSSCLERAL DELIVERY | Macusight, Inc. (US) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005027906-A1 | TRANSSCLERAL DELIVERY | MACUSIGHT, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20050064010-A1 | Transscleral delivery | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2005-03-24 | — | — | US | disclosed |